Tonix Pharmaceuticals (TNXP) Reports Q3 Loss of $0.29/Share
Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q3 EPS of ($0.29), versus ($0.72) reported last year.
For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.
